Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:109-114
Published online before print December 6, 2004, doi: 10.1161/01.HYP.0000151130.34874.fa
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/1/109    most recent
01.HYP.0000151130.34874.fav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Supowit, S. C.
Right arrow Articles by DiPette, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Supowit, S. C.
Right arrow Articles by DiPette, D. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
*High Blood Pressure
*Kidney Diseases
*Vasculitis
Related Collections
Right arrow Structure
Right arrow Animal models of human disease
Right arrow Other hypertension

(Hypertension. 2005;45:109.)
© 2005 American Heart Association, Inc.


Scientific Contributions

Calcitonin Gene-Related Peptide Protects Against Hypertension-Induced Heart and Kidney Damage

Scott C. Supowit; Arundhati Rao; Mark C. Bowers; Huawei Zhao; Gregory Fink; Barbara Steficek; Parag Patel; Khurshed A. Katki; Donald J. DiPette

From the Texas A&M University System Health Science Center (S.C.S., M.C.B., K.A.K., D.J.D.), College of Medicine and Scott & White Health System, Department of Medicine, Temple, Tex; the Department of Pathology (A.R., P.P.), Scott & White Health System, Temple, Tex; the Department of Pharmacology and Toxicology (H.Z., G.F.), and Diagnostic Center for Population and Animal Health (B.S.), Michigan State University, East Lansing, Mich.

Correspondence to Scott C. Supowit PhD, Texas A&M University Medical Research Building, 702 SW H.K. Dodgen Loop, Temple, TX 76504. E-mail ssupowit{at}swmail.sw.org

Calcitonin gene-related peptide is a potent vasodilator neuropeptide that is localized in perivascular sensory nerves. To determine whether {alpha}-calcitonin gene-related peptide possesses protective activity against hypertension-induced end organ damage, hypertension was induced in {alpha}-calcitonin gene-related/calcitonin peptide knockout and wild-type mice by uninephrectomy, deoxycorticosteroid administration, and 0.9% saline drinking water. These mice were instrumented previously for long-term telemetric blood pressure recording. Control groups were sham-operated and given tap water. Mean arterial pressures were determined, and 3 weeks after initiation of each protocol, tissues were taken for histopathologic studies. The deoxycorticosteroid-salt protocol produced a significant 35% mean arterial pressure increase in both mouse strains. No pathological changes were observed in sections of aortas and femoral arteries from any of the groups studied. Likewise, heart and kidney sections from the hypertensive wild-type mice showed no pathological changes compared with their normotensive counterparts. In contrast, marked vasculitis was seen in the heart sections from the deoxycorticosteroid-salt–treated {alpha}-calcitonin gene-related peptide knockout mice with thickening and inflammation of the vessel walls. In addition, myocarditis and focal epicarditis with areas of myocardial necrosis were present. Kidneys of these mice exhibited prominent glomerular changes including congestion of the capillary loops, focal mesangial and crescent proliferation, and focal histocytic infiltration. Urinary microalbumin was significantly higher in the hypertensive {alpha}-calcitonin gene-related peptide knockout compared with hypertensive wild-type mice. These data suggest that deletion of the {alpha}-calcitonin gene-related peptide gene makes the heart and kidneys more vulnerable to hypertension-induced end organ damage.


Key Words: hypertension, experimental • mice • calcitonin gene-related peptide • blood pressure




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Ditting, G. Tiegs, K. Rodionova, P. W. Reeh, W. Neuhuber, W. Freisinger, and R. Veelken
Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney?
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1427 - F1434.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. G. R. De Mey, R. Megens, and G. E. Fazzi
Functional Antagonism between Endogenous Neuropeptide Y and Calcitonin Gene-Related Peptide in Mesenteric Resistance Arteries
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 930 - 937.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Huang, A. Karve, I. Shah, M. C. Bowers, D. J. DiPette, S. C. Supowit, and G. S. Abela
Deletion of the mouse {alpha}-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1291 - H1297.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Linz, K. Amann, W. Freisinger, T. Ditting, K. F. Hilgers, and R. Veelken
Sensory Neurons With Afferents From Hind Limbs: Enhanced Sensitivity in Secondary Hypertension
Hypertension, March 1, 2006; 47(3): 527 - 531.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. Bowers, K. A. Katki, A. Rao, M. Koehler, P. Patel, A. Spiekerman, D. J. DiPette, and S. C. Supowit
Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage
Hypertension, July 1, 2005; 46(1): 51 - 57.
[Abstract] [Full Text] [PDF]